Pfizer

CHALLANGE​
​
A global pharmaceutical company struggled to expedite drug discovery in neurodegenerative diseases, facing hurdles in identifying viable targets and optimizing clinical trial design.
SOLUTION
​
Pfizer faced challenges in accelerating research in immuno-oncology and identifying new drug targets and combination therapies. As part of IBM team, we leveraged Watson’s machine learning and cognitive tools, to enhance the identification of drug targets, optimize patient selection strategies, and accelerate the development of combination therapies. This led to improved research efficiency, enabling faster innovation in cancer treatment
RESULTS
​
By integrating AI-powered analytics and predictive modeling, we enhanced biomarker identification, streamlined patient recruitment, and accelerated drug development, leading to more efficient breakthroughs in treatment.